BNP Paribas Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
44,927
-1,799
-4% -$448K 0.01% 666
2025
Q4
$12.9M Sell
46,726
-42,677
-48% -$11.7M 0.01% 632
2025
Q3
$23.4M Buy
89,403
+38,067
+74% +$9.25M 0.06% 312
2025
Q2
$11.2M Sell
51,336
-7,581
-13% -$1.62M 0.03% 438
2025
Q1
$13.2M Buy
58,917
+19,649
+50% +$5.42M 0.04% 402
2024
Q4
$12.9M Sell
39,268
-6,956
-15% -$2.19M 0.03% 414
2024
Q3
$13.9M Sell
46,224
-3,317
-7% -$1.02M 0.03% 382
2024
Q2
$16.3M Sell
49,541
-8,159
-14% -$2.88M 0.04% 334
2024
Q1
$22.8M Sell
57,700
-40,348
-41% -$14.9M 0.06% 284
2023
Q4
$34.5M Buy
98,048
+6,395
+7% +$2.26M 0.1% 234
2023
Q3
$34.4M Buy
91,653
+2,065
+2% +$799K 0.11% 214
2023
Q2
$34.3M Buy
89,588
+5,344
+6% +$1.91M 0.11% 211
2023
Q1
$29.2M Sell
84,244
-22,825
-21% -$6.67M 0.1% 220
2022
Q4
$25.2M Buy
107,069
+3,548
+3% +$841K 0.09% 259
2022
Q3
$25.5M Buy
103,521
+14,154
+16% +$4.31M 0.1% 233
2022
Q2
$27M Sell
89,367
-10,203
-10% -$3.32M 0.1% 224
2022
Q1
$40.9M Sell
99,570
-9,387
-9% -$3.67M 0.14% 179
2021
Q4
$51.1M Buy
108,957
+39,663
+57% +$17.1M 0.17% 142
2021
Q3
$29.4M Buy
69,294
+1,339
+2% +$564K 0.11% 221
2021
Q2
$24.4M Buy
67,955
+30,597
+82% +$10.1M 0.09% 270
2021
Q1
$10.5M Sell
37,358
-628
-2% -$180K 0.04% 405
2020
Q4
$10.8M Buy
37,986
+1,599
+4% +$449K 0.05% 371
2020
Q3
$10M Buy
36,387
+6,476
+22% +$1.71M 0.06% 324
2020
Q2
$6.79M Buy
29,911
+6,615
+28% +$1.3M 0.05% 373
2020
Q1
$3.55M Buy
23,296
+2,628
+13% +$405K 0.03% 461
2019
Q4
$3.11M Buy
+20,668
New +$3.01M 0.02% 549

Other funds holding WST